UNSPSC 51145202: Levofacetoperane or levophacetoperane

This classification denotes a cns stimulant with the molecular formula C15H21NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3SZ9ZII529, chemically known as 2-piperidinemethanol, alpha-phenyl-, acetate (ester), (r*,r*)-(-)- but more generally known as levofacetoperane, which bears US NIH Compound Identifier 65715. European Medicines Agency schedules Levofacetoperane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08469MIG.

UNSPSC 51145202 Levofacetoperane or levophacetoperane is a Commodity code that does not map cleanly to the recent state and local opportunities tagged under it. The three recent solicitations recovered under this code — a Seminole County naloxone and drug deactivation systems procurement, a Texas HHS pharmacy direct-to-manufacturer RFI, and a Minnesota cooperative purchasing alliance generic pharmaceuticals RFP — address naloxone, prescription fulfillment services, and generic over-the-counter medications respectively, none of which are levofacetoperane or closely related compounds. The mismatch suggests either tagging error on the issuing bodies' side or that the code itself is rarely used in current state and local procurement practice. No recent opportunities in the source actually solicit levofacetoperane.

The three unrelated opportunities indicate activity across state health departments, county public health agencies, and multistate cooperative purchasing vehicles, with geographic spread across Florida, Texas, and Minnesota. Seminole County issued an IFB (deadline July 26, 2023) for naloxone and drug deactivation systems with annual volumes of 1,900 and 800 units respectively; Texas HHS posted an RFI (deadline April 3, 2026) to explore direct-to-manufacturer pharmacy contracting; and the Minnesota Department of Administration's Office of State Procurement issued an RFP (deadline March 26, 2026) for generic and OTC pharmaceuticals through MMCAP, a multistate cooperative vehicle. Given the code's apparent disuse for its nominal commodity and the absence of solicitations actually targeting levofacetoperane, pursuit under this code is not supported by current procurement activity.